UCB Share Price

Equities

UCB

BE0003739530

Pharmaceuticals

Market Closed - Euronext Bruxelles 16:37:04 14/06/2024 BST 5-day change 1st Jan Change
137.8 EUR +1.40% Intraday chart for UCB +6.04% +74.71%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 5.64B 6.04B 476B Sales 2025 * 6.4B 6.85B 541B Capitalization 26.16B 27.99B 2,208B
Net income 2024 * 411M 440M 34.7B Net income 2025 * 876M 938M 73.96B EV / Sales 2024 * 4.93 x
Net Debt 2024 * 1.67B 1.79B 141B Net Debt 2025 * 816M 873M 68.89B EV / Sales 2025 * 4.21 x
P/E ratio 2024 *
66 x
P/E ratio 2025 *
30.2 x
Employees 8,767
Yield 2024 *
1.02%
Yield 2025 *
1.05%
Free-Float 61.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.40%
1 week+6.04%
Current month+7.15%
1 month+12.48%
3 months+32.04%
6 months+89.98%
Current year+74.71%
More quotes
1 week
128.85
Extreme 128.85
138.55
1 month
120.55
Extreme 120.55
138.55
Current year
78.72
Extreme 78.72
138.55
1 year
65.40
Extreme 65.4
138.55
3 years
65.40
Extreme 65.4
138.55
5 years
60.18
Extreme 60.18
138.55
10 years
54.84
Extreme 54.84
138.55
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 31/05/11
Director of Finance/CFO 57 30/06/20
Chief Tech/Sci/R&D Officer 63 30/09/17
Members of the board TitleAgeSince
Director/Board Member 66 27/04/16
Director/Board Member 73 31/12/13
Chief Executive Officer 65 31/05/11
More insiders
Date Price Change Volume
14/06/24 137.8 +1.40% 265,472
13/06/24 136 +0.52% 222,728
12/06/24 135.2 +2.93% 356,161
11/06/24 131.4 +1.04% 655,061
10/06/24 130 +0.04% 268,269

Real-time Euronext Bruxelles, June 14, 2024 at 04:37 pm

More quotes
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
137.8 EUR
Average target price
135 EUR
Spread / Average Target
-2.09%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW